If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
73.20    1.20 (1.67%)
Bid:
72.00
Ask:
72.80
Spread: 0.80 (1.111%)
Market Cap: £98.80m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

AGM, IMS & Trading Update

11 Aug 2011 12:19

RNS Number : 2062M
Trifast PLC
11 August 2011
 



 

Thursday, 11 August 2011

 

Trifast plc('Trifast' or 'the Company')

Annual General Meeting

Interim Management Statement & Trading Update

 

At today's Annual General Meeting, Malcolm Diamond, Executive Chairman, addressed shareholders and all Resolutions were duly passed. Details of the proxy votes will be provided on the Group's website, www.trifast.com or on request from the Company Secretary.

 

The Company also issued the following Interim Management Statement which covers the period from 1 April to 30 June 2011 and a Trading Update to the date of this announcement.

 

The Board is encouraged by the business performance which has seen revenue growth over the comparable period last year and more importantly a solid increase in profitability. Even with the traditionally quieter weeks of summer and the potential fragility of some economies and industries, we are continuing to witness further business opportunities in our key market sectors.

 

In-house manufacturing and strong sector focus underpins Trifast's powerful customer offering both locally and globally. Trifast's business models in both Europe and Asia are now well defined and firmly established. This year, we are looking to consolidate and then grow our customer support and logistics resource in the USA by initiating the restructure of our business teams to separate OEM sales and distribution into a new warehouse in Houston, and our Branded Products team into a new warehouse just outside Boston.

 

Looking forward; as we highlighted in both our 2011 published Report & Accounts and presentations in June, our focus in this new financial year will be on:-

·; Selective contract price increases

·; Improved sourcing

·; Growth within Branded Products and TR Direct (transactional sales)

·; Increased sales focus on our USA and China operations

 

As a Board, we are delighted to report that there has already been progress in all these areas which has had a positive impact not only on our teams around the globe but also on some of our key financial KPI objectives.

 

Continued focus on working capital management to support the growth mentioned above has ensured net debt remains at similar levels to those reported in our 2011 published Report & Accounts and is in-line with Management expectations.

 

Building from a firm foundation and given this positive start to the year, the Directors remain confident about Trifast's prospects and look forward to updating shareholders further on its performance at the Half-year stage.

 

Enquiries:

 

Trifast plc

 

Citigate Dewe Rogerson

Arden Partners plc

Malcolm Diamond MBE, Executive Chairman

 

Jim Barker, Chief Executive

 

Fiona Tooley, Director

Mark Belton, Group Finance Director

Keith Gabriel, Senior Account Manager

 

Adrian Trimmings

Telephone: +44 (0) 1825 747366

Telephone: +44(0) 121 362 4035

Tel: +44 (0) 20 7614 5920

Mobile: +44 (0) 7785 703523 (FT)

 

Editors Note:

LSE Ticker: TRI

www.trifast.com

Trifast's trading business TR Fastenings is a leading international manufacturer and distributor of industrial fastenings to the assembly industries, with operations in Europe, the Americas and Asia. For more information, please visit www.trfastenings.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBBGDILBBBGBB
Date   Source Headline
4th Jul 20228:00 amRNSNotice of 2022 Annual results
7th Jun 20225:56 pmRNSHolding(s) in Company - Replacement
7th Jun 20224:28 pmRNSHolding(s) in Company
1st Jun 20227:01 amRNSDirector Declaration
25th May 20222:36 pmRNSTotal Voting Rights
24th May 20227:00 amRNSNotice of Results - Amendment to timing of release
17th May 20227:00 amRNSHolding(s) in Company
5th May 20224:40 pmRNSSecond Price Monitoring Extn
5th May 20224:35 pmRNSPrice Monitoring Extension
5th May 20227:00 amRNSTrading update & Notice of Annual results
20th Apr 20229:51 amRNSBlock listing Interim Review
6th Apr 20224:40 pmRNSSecond Price Monitoring Extn
6th Apr 20224:35 pmRNSPrice Monitoring Extension
16th Mar 20224:35 pmRNSPrice Monitoring Extension
14th Mar 20225:30 pmRNSTotal Voting Rights
14th Mar 20221:47 pmRNSHolding(s) in Company
9th Mar 20224:36 pmRNSPrice Monitoring Extension
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20221:23 pmRNSHolding(s) in Company
3rd Mar 20225:10 pmRNSHolding(s) in Company
24th Feb 20227:00 amRNSQ3 Trading Update
2nd Feb 202211:32 amRNSTotal Voting Rights
7th Dec 20211:15 pmRNSDirector/PDMR Shareholding
3rd Dec 20214:22 pmRNSTotal Voting Rights
23rd Nov 20217:00 amRNSHALF-YEARLY FINANCIAL REPORT TO 30 SEPTEMBER 2021
11th Nov 20211:48 pmRNSHolding(s) in Company
21st Oct 20217:00 amRNSTrading update and Notice of half-year results
1st Oct 202112:00 pmRNSBlock listing Interim Review
1st Sep 20217:00 amRNSTR acquisition -enhancing North American offering
4th Aug 20214:27 pmRNSLTIP Grant and Total Voting Rights
29th Jul 20214:27 pmRNSResult of AGM
28th Jul 20217:00 amRNSAGM Statement to Shareholders
26th Jul 20215:19 pmRNSAnnual General Meeting -shareholderupdate
29th Jun 20214:35 pmRNSPrice Monitoring Extension
28th Jun 20215:51 pmRNSAvailability of 2021 Annual Financial Report
28th Jun 20214:35 pmRNSPrice Monitoring Extension
22nd Jun 20217:00 amRNS2021 Annual Results - year ended 31 March 2021
14th Jun 202110:29 amRNSTotal Voting Rights
23rd Apr 202112:32 pmRNSHolding(s) in Company
22nd Apr 20217:00 amRNSTrading Update & Notice of Annual Results
1st Apr 20217:00 amRNSBlock listing Interim Review
1st Apr 20217:00 amRNSTotal Voting Rights
12th Mar 20215:48 pmRNSDirector/PDMR Shareholding
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
18th Feb 20217:00 amRNSTrading Update
16th Feb 20214:35 pmRNSPrice Monitoring Extension
16th Feb 20212:54 pmRNSHolding(s) in Company
12th Feb 202111:41 amRNSLTIP awards targets and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.